CLASS II ONGOING Device recall · Reported 15 Nov 2023 · FDA Enforcement Report

Vitros Chemistry Products Lipase Slides recalled

Ortho-Clinical Diagnostics is recalling Vitros Chemistry Products Lipase Slides, distributed in 12 states. The recall was initiated on 12 Sep 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesProduct Code 1668409: UDI-DI: 10758750009510, Affected Lots: 5905-3348-1557; Product Code 8297749: UDI-DI: 10758750004683, Affected Lots: 5905-3348-2899
Quantity recalled342 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0236-2024
FDA event ID
93238
Recalling firm
Ortho-Clinical Diagnostics, Rochester, NY
Classification
Class II
Status
Ongoing
Recall initiated
12 Sep 2023
FDA classified
6 Nov 2023
Reported
15 Nov 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 Sep 2023Recall initiated by company
6 Nov 2023Classified by FDA+55 days
15 Nov 2023Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Products 1668409 and 8297749 may contain VITROS Lipase Slides with an abnormality which could cause -46% to +86% bias in lipase results depending on how the slides are used. Falsely low levels could result in a missed or delayed diagnosis of acute pancreatitis and may lead to diagnostic confusion in the setting of acute abdominal symptoms. Falsely elevated levels would not result in patient harm but may cause diagnostic confusion and a delay in accurate diagnosis of a patient with abdominal pain.

Product as listed by the FDA

VITROS Chemistry Products Lipase Slides, Product Codes 1668409 (contains 60 Slides per Cartridge) and 8297749 (contains 18 slides per cartridge)

Where it was distributed

US States: CA, CO, FL, GA, IL, IN, KS, NC, NY, TN, TX, VT. Canada, France, India, Japan, South Korea

CaliforniaColoradoFloridaGeorgiaIllinoisIndianaKansasNorth CarolinaNew YorkTennesseeTexasVermont

Questions about this recall

Why was it recalled?

Products 1668409 and 8297749 may contain VITROS Lipase Slides with an abnormality which could cause -46% to +86% bias in lipase results depending on how the slides are used. Falsely low levels could result in a missed or delayed diagnosis of acute pancreatitis and may lead to diagnostic confusion in the setting of acute abdominal symptoms. Falsely elevated levels would not result in patient harm but may cause diagnostic confusion and a delay in accurate diagnosis of a patient with abdominal pain.

Which lots are affected?

Product Code 1668409: UDI-DI: 10758750009510, Affected Lots: 5905-3348-1557; Product Code 8297749: UDI-DI: 10758750004683, Affected Lots: 5905-3348-2899

Where was it sold?

US States: CA, CO, FL, GA, IL, IN, KS, NC, NY, TN, TX, VT. Canada, France, India, Japan, South Korea

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ortho-Clinical Diagnostics

All 311

Other Other Medical Devices recalls

All 13,778